Geographic atrophy (GA) is a common cause of visual loss. The UK population prevalence is unknown. We studied GA prevalence, characteristics, and associations in an elderly UK population.
Masked grading of colour fundus photographs from 3549 participants in the cross-sectional study of Bridlington residents aged ≥65 years. GA size, shape and foveal involvement were correlated with demography and vision.
GA was detected in 130 eyes (101 individuals) of 3480 participants with gradable images (prevalence 2.90%; 95% CI 2.39–3.52 either eye), was bilateral in 29/3252 subjects (0.89%, 95% CI 0.62–1.28) with bilateral gradable photos, with mean age of 79.26 years (SD 6.99, range 67–96). Prevalence increased with age, from 1.29% (95% CI 0.69–2.33) at 65–69 to 11.96% (95% CI 7.97–17.50) at 85–90 years. Mean GA area was 4.51 mm2 (SD 6.48, 95% CI 3.35–5.66); lesions were multifocal in 47/130 eyes (36.2%; 95% CI 28.4–44.7). Foveal involvement occurred in 41/130 eyes (31.5%; 95% CI 24.2–40.0). In eccentric GA, mean distance from circumference to fovea was 671μm (SD 463; 95% CI 570–773). Older age (OR 1.10/year increase; 95% CI 1.06–1.14), RPD (OR 1.87; 95% CI 1.10–3.19) and large drusen/RPD ≥ 125 μm (OR 6.16; 95% CI 3.51–10.75) were significantly associated with GA in multivariate analysis. GA lesions (18/31 eyes; 58%; 95% CI 40.7–73.6) had U-shape configuration more frequently in RPD subjects than those without (9/99 eyes, 9.1%; 95% CI 4.66–16.6) (p = 0.0001).
GA, commonly solitary and eccentric, occurred in the perifovea. However, one third of GA eyes had foveal and bilateral involvement. Possible association of RPD with GA phenotype exists. Population multimodal imaging studies may improve understanding further.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–85.
Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653–8.
Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106:1768–79.
Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90:206–17.
Schmitz-Valckenberg S, Fleckenstein M, Helb HM, Charbel Issa P, Scholl HP, Holz FG. In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Investig Ophthalmol Vis Sci. 2009;50:3915–21.
Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999;5:25.
Sunness JS, Rubin GS, Applegate CA, Bressler NM, Marsh MJ, Hawkins BS, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997;104:1677–91.
Sunness JS, Rubin GS, Zuckerbrod A, Applegate CA. Foveal-sparing scotomas in advanced dry age-related macular degeneration. J Vis Impair Blind. 2008;102:600–10.
Sunness JS, Margalit E, Srikumaran D, Applegate CA, Tian Y, Perry D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007;114:271–7.
Calabrese A, Bernard JB, Hoffart L, Faure G, Barouch F, Conrath J, et al. Wet versus dry age-related macular degeneration in patients with central field loss: different effects on maximum reading speed. Investig Ophthalmol Vis Sci. 2011;52:2417–24.
Mauschitz MM, Fonseca S, Chang P, Gobel AP, Fleckenstein M, Jaffe GJ, et al. Topography of geographic atrophy in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2012;53:4932–9.
Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, Bird AC. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology. 2005;112:132–8.
Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird AC. The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol. 2003;121:379–85.
Joachim N, Mitchell P, Rochtchina E, Tan AG, Wang JJ. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort. Ophthalmology. 2014;121:917–25.
Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933–43.
Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008;146:692–9.
Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109:1092–7.
Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106:910–9.
Yehoshua Z, Rosenfeld PJ, Gregori G, Feuer WJ, Falcao M, Lujan BJ, et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology. 2011;118:679–86.
Klein ML, Ferris FL 3rd, Armstrong J, Hwang TS, Chew EY, Bressler SB, et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115:1026–31.
Wilde C, Poostchi A, Mehta RL, MacNab HK, Hillman JG, Vernon SA, et al. Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study. Eye. 2017;31:1042–50.
Fleckenstein M, Schmitz-Valckenberg S, Lindner M, Bezatis A, Becker E, Fimmers R, et al. The “diffuse-trickling” fundus autofluorescence phenotype in geographic atrophy. Investig Ophthalmol Vis Sci. 2014;55:2911–20.
Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina. 1995;15:183–91.
Marsiglia M, Boddu S, Bearelly S, Xu L, Breaux BE Jr., Freund KB, et al. Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Investig Ophthalmol Vis Sci. 2013;54:7362–9.
Xu L, Blonska AM, Pumariega NM, Bearelly S, Sohrab MA, Hageman GS, et al. Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina. 2013;33:1850–62.
Pumariega NM, Smith RT, Sohrab MA, Letien V, Souied EH. A prospective study of reticular macular disease. Ophthalmology. 2011;118:1619–25.
Sunness JS, Bressler NM, Tian Y, Alexander J, Applegate CA. Measuring geographic atrophy in advanced age-related macular degeneration. Investig Ophthalmol Vis Sci. 1999;40:1761–9.
Schmitz-Valckenberg S, Sahel JA, Danis R, Fleckenstein M, Jaffe GJ, Wolf S, et al. Natural history of Geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study). Ophthalmology. 2016;123:361–8.
Sarks SH. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol. 1982;10:91–7.
Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552–77.
Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF, et al. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122:809–16.
Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol. 1989;107:847–52.
Joachim N, Mitchell P, Kifley A, Rochtchina E, Hong T, Wang JJ. Incidence and progression of geographic atrophy: observations from a population-based cohort. Ophthalmology. 2013;120:2042–50.
Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Investig Ophthalmol Vis Sci. 2001;42:2237–41.
Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008. Eye. 2010;24:1692–9.
Evans JR, Fletcher AE, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology. 2004;111:513–7.
Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96:752–6.
Brader HS, Ying GS, Martin ER, Maguire MG. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology. 2013;120:1871–9.
Fleckenstein M, Schmitz-Valckenberg S, Martens C, Kosanetzky S, Brinkmann CK, Hageman GS, et al. Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Investig Ophthalmol Vis Sci. 2011;52:3761–6.
Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol. 1985;69:397–403.
Cukras C, Agron E, Klein ML, Ferris FL 3rd, Chew EY, Gensler G, et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report no. 28. Ophthalmology. 2010;117:489–99.
Klein R, Meuer SM, Knudtson MD, Iyengar SK, Klein BE. The epidemiology of retinal reticular drusen. Am J Ophthalmol. 2008;145:317–26.
Buitendijk GH, Hooghart AJ, Brussee C, de Jong PT, Hofman A, Vingerling JR, et al. Epidemiology of reticular pseudodrusen in age-related macular degeneration: the Rotterdam study. Investig Ophthalmol Vis Sci. 2016;57:5593–601.
Finger RP, Chong E, McGuinness MB, Robman LD, Aung KZ, Giles G, et al. Reticular pseudodrusen and their association with age-related macular degeneration: the Melbourne Collaborative Cohort Study. Ophthalmology. 2016;123:599–608.
Wilde C, Patel M, Lakshmanan A, Morales MA, Dhar-Munshi S, Amoaku WM. Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age-related macular degeneration. Eur J Ophthalmol. 2016;26:128–34.
Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology. 2010;117:1775–81.
Cohen SY, Dubois L, Tadayoni R, Delahaye-Mazza C, Debibie C, Quentel G. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation. Br J Ophthalmol. 2007;91:354–9.
Finger RP, Wu Z, Luu CD, Kearney F, Ayton LN, Lucci LM, et al. Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. Ophthalmology. 2014;121:1252–6.
Querques G, Canoui-Poitrine F, Coscas F, Massamba N, Querques L, Mimoun G, et al. Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Investig Ophthalmol Vis Sci. 2012;53:1264–70.
Knudtson MD, Klein R, Klein BE, Lee KE, Meuer SM, Tomany SC. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Investig Ophthalmol Vis Sci. 2004;45:2135–42.
Sarks J, Arnold J, Ho IV, Sarks S, Killingsworth M. Evolution of reticular pseudodrusen. Br J Ophthalmol. 2011;95:979–85.
Steinberg JS, Fleckenstein M, Holz FG, Schmitz-Valckenberg S. Foveal sparing of reticular drusen in eyes with early and intermediate age-related macular degeneration. Investig Ophthalmol Vis Sci. 2015;56:4267–74.
Curcio CA, Messinger JD, Sloan KR, McGwin G, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina. 2013;33:265–76.
Brader HS, Ying GS, Martin ER, Maguire MG. Complications of age-related macular degeneration prevention trial CRG. New grading criteria allow for earlier detection of geographic atrophy in clinical trials. Investig Ophthalmol Vis Sci. 2011;52:9218–25.
This research was funded in part by a Research Grant from the Macular Society UK, Andover, Hants and an unrestricted grant from Guide Dogs for the Blind, Reading, Berkshire, UK. The BEAP was funded by an unrestricted grant from Pfizer. We would also like to thank the following organisations for financial support of the Project: Pharmacia, Yorkshire Wolds and Coast Primary Care Trust, The Lords Feoffees of Bridlington, Bridlington Hospital League of Friends, The Hull and East Riding Charitable Trust, The National Eye Research Centre (Yorkshire), The Rotary Club of Bridlington, The Alexander Pigott Wernher Memorial Trust, Bridlington Lions Club, The Inner Wheel Club of Bridlington, Soroptimist International of Bridlington, and The Patricia and Donald Shepherd Charitable Trust.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wilde, C., Poostchi, A., Hillman, J.G. et al. Characteristics of Geographic atrophy in an elderly UK population—The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002–2006). Eye (2020). https://doi.org/10.1038/s41433-020-01169-3